Status:
RECRUITING
Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement
Lead Sponsor:
Al-Azhar University
Conditions:
Implant Dentistry
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for ...
Detailed Description
A comparative study for ridge augmentation procedure, With two groups. First group underwent a surgical ridge splitting procedure with ultrasonic bone surgery and grafting with Xenograft alone and imp...
Eligibility Criteria
Inclusion
- Adults (age 18-30) exhibiting initial insufficiently bone width.
- Patients with good oral hygiene.
- Patients must be free from systemic diseases that may influence the outcome of the therapy.
- Patients with bony horizontal defects alone, Class III \& IV.
Exclusion
- Heavy smokers.
- Patient treated by immunosuppressive chemotherapy or radio therapy,
- Allergy to any material or medication used in the study.
- Pregnant females.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06585852
Start Date
August 1 2023
End Date
October 15 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Azhar University of Cairo
Cairo, Nasr City, Egypt